ACELRX PHARMACEUTICALS INC Insider Trading for March 2014

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in ACELRX PHARMACEUTICALS INC.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of insider trading in ACELRX PHARMACEUTICALS INC for March 2014.

<<< Back to the month list

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Mar 19 2014ACRXACELRX PHARMACEUTI ...Hamel Lawrence GChief Development O ...Option ExerciseD1.202,3052,7666,675
Mar 19 2014ACRXACELRX PHARMACEUTI ...Hamel Lawrence GChief Development O ...Option ExerciseD1.202,9113,4930
Mar 19 2014ACRXACELRX PHARMACEUTI ...Hamel Lawrence GChief Development O ...SellD12.581,00012,58052,05053.1 K to 52.1 K (-1.89 %)
Mar 19 2014ACRXACELRX PHARMACEUTI ...Hamel Lawrence GChief Development O ...GrantA1.205,2166,25953,05047.8 K to 53.1 K (+10.90 %)
Mar 11 2014ACRXACELRX PHARMACEUTI ...EDWARDS MARK GDirectorOption ExerciseD3.119,37529,1563,125
Mar 11 2014ACRXACELRX PHARMACEUTI ...EDWARDS MARK GDirectorOption ExerciseD3.2511,66637,9153,334
Mar 11 2014ACRXACELRX PHARMACEUTI ...EDWARDS MARK GDirectorSellD12.1521,041255,63660,00081 K to 60 K (-25.96 %)
Mar 11 2014ACRXACELRX PHARMACEUTI ...EDWARDS MARK GDirectorGrantA3.119,37529,15681,04171.7 K to 81 K (+13.08 %)
Mar 11 2014ACRXACELRX PHARMACEUTI ...EDWARDS MARK GDirectorGrantA3.2511,66637,91571,66660 K to 71.7 K (+19.44 %)
Mar 11 2014ACRXACELRX PHARMACEUTI ...Dasu Badri NChief Engineering O ...Payment of ExerciseF11.431,38015,77322,53023.9 K to 22.5 K (-5.77 %)
Mar 11 2014ACRXACELRX PHARMACEUTI ...Dasu Badri NChief Engineering O ...SellD12.451,00012,45223,91024.9 K to 23.9 K (-4.01 %)
Mar 11 2014ACRXACELRX PHARMACEUTI ...KING RICHARDDirectorPayment of ExerciseF11.4311,599132,577134,567146.2 K to 134.6 K (-7.94 %)
Mar 11 2014ACRXACELRX PHARMACEUTI ...Hamel Lawrence GChief Development O ...Payment of ExerciseF11.431,56917,93447,83449.4 K to 47.8 K (-3.18 %)
Mar 11 2014ACRXACELRX PHARMACEUTI ...WAN MARK ADirectorSellS12.3611,250139,050126,153137.4 K to 126.2 K (-8.19 %)
Mar 11 2014ACRXACELRX PHARMACEUTI ...WAN MARK ADirectorSellS11.964595,490137,403137.9 K to 137.4 K (-0.33 %)
Mar 11 2014ACRXACELRX PHARMACEUTI ...WAN MARK ADirectorSellS12.391,75921,791137,862139.6 K to 137.9 K (-1.26 %)
Mar 11 2014ACRXACELRX PHARMACEUTI ...WAN MARK ADirectorSellS12.36509,5206,297,6675,713,5696.2 M to 5.7 M (-8.19 %)
Mar 11 2014ACRXACELRX PHARMACEUTI ...WAN MARK ADirectorSellS11.9620,800248,7686,223,0896.2 M to 6.2 M (-0.33 %)
Mar 11 2014ACRXACELRX PHARMACEUTI ...WAN MARK ADirectorSellS12.3979,645986,6586,243,8896.3 M to 6.2 M (-1.26 %)
Mar 11 2014ACRXACELRX PHARMACEUTI ...WAN MARK ADirectorSellS12.3616,049198,366179,962196 K to 180 K (-8.19 %)
Mar 11 2014ACRXACELRX PHARMACEUTI ...WAN MARK ADirectorSellS11.966557,834196,011196.7 K to 196 K (-0.33 %)
Mar 11 2014ACRXACELRX PHARMACEUTI ...WAN MARK ADirectorSellS12.392,50831,070196,666199.2 K to 196.7 K (-1.26 %)
Mar 11 2014ACRXACELRX PHARMACEUTI ...WAN MARK ADirectorSellS12.36298,5083,689,5593,347,3573.6 M to 3.3 M (-8.19 %)
Mar 11 2014ACRXACELRX PHARMACEUTI ...WAN MARK ADirectorSellS11.9612,186145,7453,645,8653.7 M to 3.6 M (-0.33 %)
Mar 11 2014ACRXACELRX PHARMACEUTI ...WAN MARK ADirectorSellS12.3946,661578,0463,658,0513.7 M to 3.7 M (-1.26 %)
Mar 11 2014ACRXACELRX PHARMACEUTI ...HOFFMAN STEPHEN JDirectorSellJ0.001,300,00002,871,9334.2 M to 2.9 M (-31.16 %)
Mar 11 2014ACRXACELRX PHARMACEUTI ...Skyline Venture Partners Quali ...SellJ0.001,300,00002,871,9334.2 M to 2.9 M (-31.16 %)